Decade Capital Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Decade Capital Management’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$440K	Buy	+60,000	New	+$611K	0.1%	106

Other funds holding FOMX

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Decade Capital Management's FOMX Position: Q3 2015 in Review

Decade Capital Management opened a new position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q3 2015: 60,000 shares worth $440K. The stake represents 0.1% of the portfolio and ranks #106 among its holdings.

77 funds tracked by Wall St. Rank hold FOMX as of Q3 2015.

Decade Capital Management held 60,000 shares of Foamix Pharmaceuticals Ltd. Ordinary Shares worth $440K as of Q3 2015.
Foamix Pharmaceuticals Ltd. Ordinary Shares was a new Decade Capital Management position in Q3 2015.
Foamix Pharmaceuticals Ltd. Ordinary Shares made up 0.1% of Decade Capital Management's portfolio in Q3 2015, its #106 holding.
77 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q3 2015.

Based on Decade Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.